Literature DB >> 705689

The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy.

H Bounameaux, F Duckert, M Walter, Y Bounameaux.   

Abstract

At III levels measured with six methods in 36 people: 10 healthy controls, 10 women taking a progestagen Lynestrenol and 16 women taking a combined oestrogen-progestagen contraceptive pill. The reproducibility and the sensitivity of these methods as well as the correlation between methods were studied. The Hensen and Loeliger technique had a poor reproducibility and the results obtained with the Howie technique were not in good correlation with those obtained with other methods, especially in the group taking oral contraceptives. The two amidolytic methods using chromogenic substrates were found to be very accurate for antithrombin III activity determination. The rocket immunoelectrophoresis was more accurate and more practical than the radial immunodiffusion. With all methods--except the one of Howie--the 10 women taking progestagen Lynestrenol and the 16 taking combined oestrogen-progestagen had a low AT III and differed significantly from the 10 normals tested. No difference was observed between women taking progestagen only or an oestrogen-progestagen combination.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 705689

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Authors:  A Girolami; F Fabris; G Cappellato; L Sainati; G Boeri
Journal:  Blut       Date:  1983-08

2.  Comparison of three methods for the estimation of plasma antithrombin.

Authors:  D S McLellan; J D Devlin; G H Heyse-Moore; A Aronstam
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

3.  The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate.

Authors:  E Varnehorst; L Wallentin; B Risberg
Journal:  Urol Res       Date:  1981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.